ITM Isotope Technologies Munich SE Email Format
Pharmaceutical ManufacturingBavaria, Germany501-1000 Employees
ITM Isotope Technologies Munich SE is a radiopharmaceutical biotechnology company focused on developing a new generation of therapeutics and diagnostics for hard-to-treat tumors. Its precision oncology portfolio combines high-quality radioisotopes with targeting molecules, supported by a pipeline that includes several Phase 3 studies across development, production, and global supply. The aim is to translate these efforts into improved patient outcomes and quality of life. Based in Garching bei München, Bavaria, ITM leverages two decades of radiopharma expertise and maintains a central industry position with an established global network to serve cancer patients, clinicians and partners. It operates within the pharmaceutical manufacturing sector and emphasizes delivering targeted treatments and diagnostics through its ongoing programs. A recent development includes presenting Phase 3 COMPETE data at ASCO 2026, reflecting progress in its clinical program.